Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Camitta

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Lancet (London, England)|March 4, 1978
A.L.G. in aplastic anaemiaB M Camitta
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Treatment of rhabdomyosarcomaB M Camitta
Haematology and Blood Transfusion|January 1, 1979
Pathogenesis of severe aplastic anemia: inferences from therapeutic trialsB M Camitta
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 1, 1984
Pathogenesis and treatment of aplastic anemiaB M Camitta
Acta Haematologica|March 8, 2000
What is the definition of cure for aplastic anemia?B M Camitta
Haematology and Blood Transfusion|January 1, 1979
The role of viral infections in aplastic anemiaB M Camitta
Progress in Clinical and Biological Research|January 1, 1984
A controlled prospective trial of antithoracic duct lymphocyte globulin (ATDLG) for treatment of severe aplastic anemiaB M Camitta
Lancet (London, England)|February 6, 1988
Criteria for severe aplastic anaemiaB M Camitta
The American Journal of Pediatric Hematology/Oncology|August 1, 1993
Acute lymphoidic leukemia in a patient with thrombocytopenia/absent radii (Tar) syndromeB M Camitta, A Rock
The American Journal of Pediatric Hematology/Oncology|January 1, 1990
Immunosuppressive therapy for aplastic anemia: indications, agents, mechanisms, and resultsB M Camitta, K Doney
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Lancet (London, England)|March 4, 1978
A.L.G. in aplastic anaemiaB M Camitta
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Treatment of rhabdomyosarcomaB M Camitta
Haematology and Blood Transfusion|January 1, 1979
Pathogenesis of severe aplastic anemia: inferences from therapeutic trialsB M Camitta
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 1, 1984
Pathogenesis and treatment of aplastic anemiaB M Camitta
Acta Haematologica|March 8, 2000
What is the definition of cure for aplastic anemia?B M Camitta
Haematology and Blood Transfusion|January 1, 1979
The role of viral infections in aplastic anemiaB M Camitta
Progress in Clinical and Biological Research|January 1, 1984
A controlled prospective trial of antithoracic duct lymphocyte globulin (ATDLG) for treatment of severe aplastic anemiaB M Camitta
Lancet (London, England)|February 6, 1988
Criteria for severe aplastic anaemiaB M Camitta
The American Journal of Pediatric Hematology/Oncology|August 1, 1993
Acute lymphoidic leukemia in a patient with thrombocytopenia/absent radii (Tar) syndromeB M Camitta, A Rock
The American Journal of Pediatric Hematology/Oncology|January 1, 1990
Immunosuppressive therapy for aplastic anemia: indications, agents, mechanisms, and resultsB M Camitta, K Doney
Pageof 12